scholarly journals Response to Comment on Tynjälä et al. Arterial Stiffness Predicts Mortality in Individuals With Type 1 Diabetes. Diabetes Care 2020;43:2266–2271

Diabetes Care ◽  
2021 ◽  
Vol 44 (4) ◽  
pp. e71-e72
Author(s):  
Anniina Tynjälä ◽  
Carol Forsblom ◽  
Valma Harjutsalo ◽  
Per-Henrik Groop ◽  
Daniel Gordin
Keyword(s):  
Type 1 Diabetes ◽  
Arterial Stiffness ◽  
Diabetes Care

scholarly journals Comment on Tynjälä et al. Arterial Stiffness Predicts Mortality in Individuals With Type 1 Diabetes. Diabetes Care 2020;43:2266–2271

Diabetes Care ◽  
2021 ◽  
Vol 44 (4) ◽  
pp. e69-e70
Author(s):  
José-Miguel González-Clemente ◽  
Gemma Llauradó ◽  
Albert Cano ◽  
Olga Giménez-Palop ◽  
Eugenia Berlanga ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Arterial Stiffness ◽  
Diabetes Care

Diabetic nephropathy and arterial stiffness in patients with type 1 diabetes mellitus

2019 ◽  
Author(s):  
Karina Sarkisova ◽  
Iwona-Renata Jarek-Martynowa ◽  
Marina Shestakova ◽  
Minara Shamkhalova ◽  
Alexander Parfenov
Keyword(s):  
Diabetes Mellitus ◽  
Type 1 Diabetes ◽  
Diabetic Nephropathy ◽  
Arterial Stiffness ◽  
Type 1 Diabetes Mellitus

scholarly journals Response to Comment on Sarkar et al. Exenatide Treatment for 6 Months Improves Insulin Sensitivity in Adults With Type 1 Diabetes. Diabetes Care 2014;37:666–670

Diabetes Care ◽  
2014 ◽  
Vol 37 (10) ◽  
pp. e219-e220
Author(s):  
Gayatri Sarkar ◽  
May Alattar ◽  
Rebecca J. Brown ◽  
Michael J. Quon ◽  
David M. Harlan ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Insulin Sensitivity ◽  
Diabetes Care

scholarly journals Diabetes Care, Glycemic Control, Complications, and Concomitant Autoimmune Diseases in Children with Type 1 Diabetes in Turkey: A Multicenter Study

2013 ◽  
Vol 5 (1) ◽  
pp. 20-26 ◽  
Author(s):  
Gökşen Şimşek Damla ◽  
Aycan Zehra ◽  
Özen Samim ◽  
Çetinkaya Semra ◽  
Kara Cengiz ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Glycemic Control ◽  
Autoimmune Diseases ◽  
Multicenter Study ◽  
Diabetes Care

scholarly journals The Rapid Transition to Telemedicine and Its Effect on Access to Care for Patients With Type 1 Diabetes During the COVID-19 Pandemic

2021 ◽  
Author(s):  
Daniel R. Tilden ◽  
Karishma A. Datye ◽  
Daniel J. Moore ◽  
Benjamin French ◽  
Sarah S. Jaser
Keyword(s):  
Type 1 Diabetes ◽  
Access To Care ◽  
Diabetes Care ◽  
Demographic Groups ◽  
Rapid Transition ◽  
English Speaking ◽  
Clinically Significant ◽  
Design And Methods ◽  
The Impact

<b>Objective: </b>We compared the uptake of telemedicine for diabetes care across multiple demographic groups during the COVID-19 pandemic to understand the impact of telemedicine adoption on access to care. <p><b>Research Design and Methods:</b> The study analyzed demographic information of patients with type 1 diabetes seen between 1/1/2018 and 6/30/2020 at a single center. We compared the odds of completing a visit via telemedicine across multiple demographic characteristics.</p> <p><b>Results: </b>Among 28,977 patient-visits, the odds of completing a visit via telemedicine were lower among non-English-speaking (1.7% vs. 2.7%, aOR:0.45, 95% CI:0.26-0.79) and Medicaid-insured (32.0% vs. 35.9%, aOR:0.83, 95% CI:0.72-0.95) pediatric patients. No clinically significant differences were observed for other demographic factors.</p> <p><b>Conclusions: </b>Rapid transition to telemedicine did not significantly impact access to diabetes care for most demographic groups. However, disparities in access to care for historically marginalized groups merit close attention to ensure use of telemedicine does not exacerbate these inequities.</p>

Sign in / Sign up

Export Citation Format

Share Document